Breaking News Headlines Today

News about Merck

Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 142 stories have been published about Merck which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

U.K. is urged to probe drugmakers for conspiring to scrap or halt investments amid pricing disputes

100% Center coverage: 1 sources

The move comes as President Trump has demanded drugmakers cut prices in the U.S. to bring them in line with those in Europe and CanadaNHS · United Kingdom Read Article

Is the U.K. Losing Its Competitive Edge in Life Sciences Amid Merck's Exit?

Merck’s recent decision to withdraw significant operations from the United Kingdom has raised fresh concerns about the country’s ability to maintain its standing as a global hub for life sciences. Once regarded as a prime destination for biotech and pharmaceutical investment, the U.K. now faces mounting challenges amid shifting economic policies, regulatory uncertainties, and competitive pressures from other international markets. This move by o…Biotech · United Kingdom See the Story

How Merck co., salesforce.com, American Express, Johnson & Johnson, Verizon and Goldman Sachs Provided Talk Material at Dow Jones

FOO: salesforce.com on 30.9. -3.30%, volume 142% normal days , AEC1: American Express on 30.9. -2.97%, volume 115% normal days , GOS: Goldman Sachs on 30.9. -0.97%, volume 102% normal days , BAC: Verizon on 30.9. 1.62%, volume 117% normal days , JNJ: Johnson & Johnson on 30.9. 2.09%, volume 129% normal days , 6MK: Merck Co. on 30.9. 6.81%, volume 144% normal days , Dow Jones: +0.18% share symbol SK Perf. Merck Co. 6MK 83.93 6.81% Johnson & Johns…American Express Read Article

Merck: Initiating "Strong Buy" On Shift To Qlex SC Injection For Solid Tumors (NYSE:MRK)

100% Right coverage: 1 sources

Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects for Merck. Read the latest analysis on the stock here.Merck Read Article

How the UK Destroyed Its Drug Industry

You may have seen that Merck has announced that it will cancel a proposed $1.3 billion research center in London and terminate its pharmaceutical R&D projects in the U.K. Why? Merck decided to pull out of Britain because of “the overall undervaluation of innovative medicines and vaccines by successive U.K. governments.” Read: DRUG PRICE CONTROLS. This isn’t the result of any sudden overnight change of heart by Merck. According to David Ricks, CE…Merck · London Read Article

Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension Patients - Merck & Co (NYSE:MRK)

100% Center coverage: 1 sources

Merck reported Phase 3 results showing Winrevair significantly reduced clinical worsening in pulmonary arterial hypertension patients.Merck · United States See the Story

Merck Appoints Kai Beckmann as Next Ceo, Strengthening Global Semiconductor Strategy

[Digital Daily Reporter Bae Tae-yong] Merck, headquartered in Darmstadt, Germany, announced on the 25th (local time) that it has appointed Kai Beckmann, CEO of its Electronics division, as the next Chairman of the Board of Management and Chief Executive Officer (CEO). Beckmann will take over from current Chairman Belén Garijo, whose term ends on May 1, 2026. Beckmann will immediately assume the role of Deputy CEO and concurrently serve as CEO of…Merck · Germany See the Story

News about Merck

News about Merck

Covered Most By

Local News Publishers

Top Merck News

Dianthus Inks Licensing Deal with Chinese Biotech; C4 Targets $125M Offering

Dianthus Inks Licensing Deal with Chinese Biotech; C4 Targets $125M Offering

The 5 Highest-Yielding Dogs of the Dow Are Among Our Top Q4 Picks

U.S. Bancorp Announces Third Quarter Earnings Conference Call Details

U.K. is urged to probe drugmakers for conspiring to scrap or halt investments amid pricing disputes

Is the U.K. Losing Its Competitive Edge in Life Sciences Amid Merck's Exit?

How Merck co., salesforce.com, American Express, Johnson & Johnson, Verizon and Goldman Sachs Provided Talk Material at Dow Jones

Merck: Initiating "Strong Buy" On Shift To Qlex SC Injection For Solid Tumors (NYSE:MRK)

How the UK Destroyed Its Drug Industry

Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension Patients - Merck & Co (NYSE:MRK)

Merck Appoints Kai Beckmann as Next Ceo, Strengthening Global Semiconductor Strategy

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Merck

Dianthus Inks Licensing Deal with Chinese Biotech; C4 Targets $125M Offering

The 5 Highest-Yielding Dogs of the Dow Are Among Our Top Q4 Picks

U.S. Bancorp Announces Third Quarter Earnings Conference Call Details

U.K. is urged to probe drugmakers for conspiring to scrap or halt investments amid pricing disputes

Is the U.K. Losing Its Competitive Edge in Life Sciences Amid Merck's Exit?

How Merck co., salesforce.com, American Express, Johnson & Johnson, Verizon and Goldman Sachs Provided Talk Material at Dow Jones

Merck: Initiating "Strong Buy" On Shift To Qlex SC Injection For Solid Tumors (NYSE:MRK)

How the UK Destroyed Its Drug Industry

Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension Patients - Merck & Co (NYSE:MRK)

Merck Appoints Kai Beckmann as Next Ceo, Strengthening Global Semiconductor Strategy